ArticleOrthopadie (Heidelberg, Germany)2025
[Arthrofibrosis after total knee arthroplasty-Diagnosis and management].
Article in Orthopadie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Patient-specific instrumentation in total knee arthroplasty - current concepts and clinical implications].Orthopadie (Heidelberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arthrofibrosis is a common complication following total knee arthroplasty (approximately 5%), characterized by painful limitation of range of motion and increased soft tissue fibrosis. Women are affected more frequently than men. A distinction is made between primary (early postoperative, global) and secondary forms (mechanical/infectious causes). Diagnosis is established clinically and confirmed histopathologically. Early non-surgical, antifibrotic treatment with physiotherapy, relaxation techniques, and, if needed, prednisolone and propranolol is recommended. If there is no improvement, mobilization under anesthesia (MUA), ideally within the first 90 days postoperatively, or arthroscopic arthrolysis should be performed. Arthrolysis, while requiring surgical intervention, shows the best improvements in range of motion, particularly at later stages. Late revision surgeries are less effective. In the future, pharmacological therapies may play a role.
Indexed as
Identifiers
40839304What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.